New Key Statistics Module, Z-Score and F-Score
OTCPK:REPCF Key Ratios
Market Cap $ M | 2.60 |
Enterprise Value $ M | 2.60 |
P/E(ttm) | 9,999.00 |
PE Ratio without NRI | 3.93 |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 9.17 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | 6.59 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 34.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -52.71 |
EV-to-EBITDA | -54.30 |
PEG | 0.11 |
Shares Outstanding M | 65.00 |
Net Margin (%) | -19.60 |
Operating Margin % | -388.92 |
Pre-tax Margin (%) | -19.89 |
Quick Ratio | 0.13 |
Current Ratio | 0.13 |
ROA % (ttm) | -10.90 |
ROE % (ttm) | -- |
ROIC % (ttm) | -111.36 |
Dividend Yield % | -- |
Altman Z-Score | -195.75 |
REPCF Number of Guru Trades
REPCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:REPCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:REPCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
RepliCel Life Sciences Inc Insider Transactions
No Available Data
News about OTCPK:REPCF
Total 0- 1